文献速递头痛与眩晕

全基因组关联研究识别丛集性头痛风险位点

Genome-Wide Association Study Identifies Risk Loci for Cluster Headache.
PubMed 文献 · Ann Neurol · 2021-07-14

该研究对852例英国和591例瑞典丛集性头痛患者及对照进行全基因组关联分析,识别出染色体2、1和6上的易感位点,其中染色体6位点与已知偏头痛位点重叠,下游分析提示免疫过程参与发病。

要点

  • 丛集性头痛存在遗传易感性,识别出多个全基因组显著关联位点。
  • 染色体6位点与已知偏头痛位点重叠,提示部分共享遗传基础。
  • 下游分析提示免疫过程可能参与丛集性头痛的发病机制。

核心结论

  • 在涉及1,443例病例的全基因组关联研究中识别并复制了多个全基因组显著关联,支持丛集性头痛的遗传易感性。

研究设计与样本

  • 全基因组关联研究,比较852例英国和591例瑞典丛集性头痛病例与5,614例和1,134例对照,经质控和插补后用逻辑混合模型进行单变异关联检验,两队列合并分析。

主要发现

  • 初始独立分析识别出染色体2上2个可复制的丛集性头痛易感位点。
  • 合并分析识别出染色体1上额外位点,并确认英国分析中染色体6上显著位点,该位点与已知偏头痛位点重叠。
  • 下游分析提示免疫过程参与丛集性头痛的发病机制。

关键数值与推荐

  • 染色体2 lead SNP rs113658130:p=1.92×10-17,OR=1.51,95%CI=1.37-1.66。
  • 染色体2 lead SNP rs4519530:p=6.98×10-17,OR=1.47,95%CI=1.34-1.61。
  • 染色体1 rs12121134:p=1.66×10-8,OR=1.36,95%CI=1.22-1.52。
  • 染色体6 rs11153082:p=1.85×10-8,OR=1.30,95%CI=1.19-1.42。

临床怎么用

  • 研究结果支持丛集性头痛的遗传易感性,提示免疫过程可能参与发病,为未来基因型-表型关联研究提供基础。

局限性

  • 需要在更大独立队列中复制,并结合全面表型分析(如治疗反应和丛集性头痛亚型)以深入理解基因型-表型关联和病理生理通路。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study was undertaken to identify susceptibility loci for cluster headache and obtain insights into relevant disease pathways. METHODS: We carried out a genome-wide association study, where 852 UK and 591 Swedish cluster headache cases were compared with 5,614 and 1,134 controls, respectively. Following quality control and imputation, single variant association testing was conducted using a logistic mixed model for each cohort. The 2 cohorts were subsequently combined in a merged analysis. Downstream analyses, such as gene-set enrichment, functional variant annotation, prediction and pathway analyses, were performed. RESULTS: Initial independent analysis identified 2 replicable cluster headache susceptibility loci on chromosome 2. A merged analysis identified an additional locus on chromosome 1 and confirmed a locus significant in the UK analysis on chromosome 6, which overlaps with a previously known migraine locus. The lead single nucleotide polymorphisms were rs113658130 (p = 1.92 × 10-17 , odds ratio [OR] = 1.51, 95% confidence interval [CI] = 1.37-1.66) and rs4519530 (p = 6.98 × 10-17 , OR = 1.47, 95% CI = 1.34-1.61) on chromosome 2, rs12121134 on chromosome 1 (p = 1.66 × 10-8 , OR = 1.36, 95% CI = 1.22-1.52), and rs11153082 (p = 1.85 × 10-8 , OR = 1.30, 95% CI = 1.19-1.42) on chromosome 6. Downstream analyses implicated immunological processes in the pathogenesis of cluster headache. INTERPRETATION: We identified and replicated several genome-wide significant associations supporting a genetic predisposition in cluster headache in a genome-wide association study involving 1,443 cases. Replication in larger independent cohorts combined with comprehensive phenotyping, in relation to, for example, treatment response and cluster headache subtypes, could provide unprecedented insights into genotype-phenotype correlations and the pathophysiological pathways underlying cluster headache. ANN NEUROL 2021;90:193-202.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. O'Connor E, Fourier C, Ran C, et al. Genome-Wide Association Study Identifies Risk Loci for Cluster Headache. Ann Neurol. 2021. PMID: 34184781. doi:10.1002/ana.26150

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。